Patent · US Expired

1,2,3,4,5,6,-hexahydroazepino [4,5-b]indoles containing arylsulfones at the 9-position

US6468999B1 · kind B1 · utility

4Cited by

13References

24Claims

0Family size

Assignee

Pharmacia & Upjohn Company LLC · US

Inventors

Eric Jon Jacobsen · Chesterfield, US
Susan Korynne Hendges · Kalamazoo, US

Key dates

Filing date	Jul 11, 2000
Grant date	Oct 22, 2002
Priority date	—
Expiry date	Jul 11, 2020

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C323/09
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention are substituted 9-arylsulfone-1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles (X) and unsubstituted 9-arylsulfone-1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles (XI) such as the compound of EXAMPLE 13 which are useful in treating depression, obesity and other CNS disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.